Norma Beauchamp

Norma Beauchamp is a declared insider of Acerus Pharmaceuticals Corporation, with filings sourced from SEDI. Between 28 August 2018 and 8 August 2019, the trades on record add up to 3 filings.

Every open-market trade on record is a purchase: 3 purchases worth €9,020, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2019 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €3,284. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

Most recently, on 9 August 2019, the filings show an open-market purchase worth €3,284 in Acerus Pharmaceuticals Corporation. The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.